Human Gene MIR302B (uc011cfz.2) Description and Page Index
  Description: Homo sapiens microRNA 302b (MIR302B), microRNA.
RefSeq Summary (NR_029857): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript is intronless :: LM608693.1 [ECO:0000345] ##Evidence-Data-END##
Transcript (Including UTRs)
   Position: hg19 chr4:113,569,030-113,569,713 Size: 684 Total Exon Count: 1 Strand: -


Page IndexSequence and LinksCTDRNA-Seq ExpressionMicroarray ExpressionOther Species
mRNA DescriptionsOther NamesModel InformationMethods
Data last updated: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr4:113,569,030-113,569,713)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSEnsembl
Entrez GeneExonPrimerHGNCLynxOMIMPubMed
Stanford SOURCE

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 9.66 RPKM in Cells - EBV-transformed lymphocytes
Total median expression: 227.90 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  DM208668 - Efficient Method for Nuclear Reprogramming.
FW393711 - Efficient Method for Nuclear Reprogramming.
CS266883 - Sequence 575 from Patent WO2005118806.
DL077045 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004695 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM176259 - A nucleics Acid regulating cell growth.
DM208665 - Efficient Method for Nuclear Reprogramming.
FU261331 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763833 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV527296 - Nucleic acid controling mast cell degranulation.
FW393708 - Efficient Method for Nuclear Reprogramming.
FW422037 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304732 - JP 2009531018-A/299: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305230 - JP 2009531019-A/299: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV534197 - WO 2011111715-A/713: Nucleic acid for controlling cell cycle.
HW119439 - JP 2013046612-A/299: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367908 - JP 2012228254-A/575: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW412301 - JP 2014000079-A/575: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589768 - JP 2013121348-A/299: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674647 - JP 2014217381-A/575: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ043029 - JP 2015510401-A/119: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067589 - JP 2014012020-A/575: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081655 - JP 2015514392-A/119: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408406 - JP 2015528002-A/1003: CHIRAL CONTROL.
HZ413572 - JP 2014060993-A/299: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ428013 - JP 2014217384-A/575: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428816 - JP 2014217385-A/575: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429619 - JP 2014217386-A/575: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430422 - JP 2014217387-A/575: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501783 - JP 2016025853-A/299: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769679 - JP 2014223080-A/575: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA059073 - Sequence 575 from Patent EP2298893.
JA059876 - Sequence 575 from Patent EP2298894.
JA074199 - Sequence 575 from Patent EP2281887.
JA105336 - Sequence 575 from Patent EP2302051.
JA106676 - Sequence 575 from Patent EP2302052.
JA107479 - Sequence 575 from Patent EP2302053.
JA108282 - Sequence 575 from Patent EP2302054.
JA109085 - Sequence 575 from Patent EP2302055.
JA109888 - Sequence 575 from Patent EP2302056.
JA192404 - Sequence 575 from Patent EP2290066.
JA193303 - Sequence 575 from Patent EP2290067.
JA194202 - Sequence 575 from Patent EP2290068.
JA195101 - Sequence 575 from Patent EP2290069.
JA196000 - Sequence 575 from Patent EP2290070.
JA196899 - Sequence 575 from Patent EP2290071.
JA197798 - Sequence 575 from Patent EP2290072.
JA198697 - Sequence 575 from Patent EP2290073.
JA199596 - Sequence 575 from Patent EP2290074.
JA200495 - Sequence 575 from Patent EP2290075.
JA201394 - Sequence 575 from Patent EP2290076.
JA218516 - Sequence 575 from Patent EP2281888.
JA226667 - Sequence 575 from Patent EP2292755.
JA229522 - Sequence 575 from Patent EP2292756.
JA257793 - Sequence 575 from Patent EP2284265.
JA279073 - Sequence 575 from Patent EP2281886.
JA284959 - Sequence 575 from Patent EP2281889.
JA293012 - Sequence 575 from Patent EP2287303.
JA318198 - Sequence 575 from Patent EP2314688.
JA375257 - Sequence 575 from Patent EP2322616.
JA526149 - Sequence 299 from Patent EP2369011.
JA526656 - Sequence 299 from Patent EP2369012.
JA527163 - Sequence 299 from Patent EP2369013.
JA536092 - Sequence 299 from Patent EP2371971.
JA788097 - Sequence 299 from Patent EP2479285.
JA788595 - Sequence 299 from Patent EP2479286.
JA810929 - Sequence 299 from Patent EP2468890.
JA811427 - Sequence 299 from Patent EP2468891.
JA811925 - Sequence 299 from Patent EP2468893.
JA812423 - Sequence 299 from Patent EP2468894.
JA812921 - Sequence 299 from Patent EP2468895.
JA813419 - Sequence 299 from Patent EP2468896.
JA813917 - Sequence 299 from Patent EP2468897.
JA814415 - Sequence 299 from Patent EP2468898.
JA814913 - Sequence 299 from Patent EP2468899.
JA817156 - Sequence 299 from Patent EP2468892.
JA825968 - Sequence 299 from Patent EP2471956.
JA826466 - Sequence 299 from Patent EP2471958.
JB024753 - Sequence 299 from Patent EP2505668.
JB025251 - Sequence 299 from Patent EP2505669.
JB079638 - Sequence 299 from Patent EP2487252.
JB080136 - Sequence 299 from Patent EP2487253.
JB080634 - Sequence 299 from Patent EP2487254.
JB081132 - Sequence 299 from Patent EP2487255.
JB081630 - Sequence 299 from Patent EP2487256.
JB082128 - Sequence 299 from Patent EP2487257.
JB082626 - Sequence 299 from Patent EP2487258.
JB083124 - Sequence 299 from Patent EP2487259.
JB083622 - Sequence 299 from Patent EP2487260.
JB084120 - Sequence 299 from Patent EP2487261.
JB084618 - Sequence 299 from Patent EP2487262.
JB085116 - Sequence 299 from Patent EP2487263.
JB087794 - Sequence 299 from Patent EP2502630.
JB147998 - Sequence 299 from Patent EP2484782.
JB148496 - Sequence 299 from Patent EP2484783.
JB153221 - Sequence 299 from Patent EP2514433.
JB153719 - Sequence 299 from Patent EP2514434.
JB622308 - Sequence 299 from Patent EP2586454.
JB622806 - Sequence 299 from Patent EP2586455.
JC001869 - Sequence 299 from Patent EP2591794.
JC222100 - Sequence 575 from Patent EP2471923.
JC268666 - Sequence 575 from Patent EP2471924.
JC340974 - Sequence 575 from Patent EP2471922.
JC470220 - Sequence 575 from Patent EP2471921.
JC991009 - Sequence 575 from Patent EP2808390.
LF404126 - JP 2015509366-A/119: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF715112 - JP 2016165292-A/575: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF857046 - JP 2015142597-A/575: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051740 - KR 1020150036642-A/1006: CHIRAL CONTROL.
MA353657 - JP 2018075017-A/119: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
CS548424 - Sequence 1454 from Patent EP1777301.
DJ087801 - Novel miRNA molecules isolated from human embryonic stem cell.
DM175228 - A nucleics Acid regulating cell growth.
FU261522 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU764024 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525556 - Nucleic acid controling mast cell degranulation.
FW312167 - DETECTING NUCLEIC ACIDS.
FW364257 - Oligonucleotides for modulating target RNA activity.
HI965139 - Sequence 424 from Patent WO2010139812.
HI966145 - Sequence 465 from Patent WO2010139811.
HI967011 - Sequence 465 from Patent WO2010139810.
HV304923 - JP 2009531018-A/490: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305421 - JP 2009531019-A/490: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV492090 - WO 2011087154-A/263: Method For Screening Induced Pluripotent Stem Cells.
HV533765 - WO 2011111715-A/281: Nucleic acid for controlling cell cycle.
HV595166 - JP 2010539959-A/547: Micromirs.
HV954125 - JP 2012518421-A/1037: METHODS OF DETECTING LUNG CANCER.
HW119630 - JP 2013046612-A/490: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW262294 - JP 2013516982-A/263: Method For Screening Induced Pluripotent Stem Cells.
HW589959 - JP 2013121348-A/490: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW608550 - JP 2014515024-A/39: Micro-RNA Inhibitors and Their Uses in Disease.
HZ042954 - JP 2015510401-A/44: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074193 - JP 2013535982-A/284: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081580 - JP 2015514392-A/44: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ157723 - JP 2015130862-A/547: Micromirs.
HZ186570 - JP 2015146814-A/319: Oligonucleotides for modulating target RNA activity.
HZ413763 - JP 2014060993-A/490: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ480313 - JP 2015535430-A/819: TERMINALLY MODIFIED RNA.
HZ501974 - JP 2016025853-A/490: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ531297 - JP 2016502527-A/19: miRNAs AS NOVEL THERAPEUTIC ADJUVANTS AND BIOMARKERS FOR THE PROGNOSIS AND TREATMENT OF DRUG RESISTANT BREAST CANCERS.
HZ790244 - JP 2016504050-A/1989: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401177 - Sequence 424 from Patent WO2011080318.
JA402155 - Sequence 424 from Patent WO2011080315.
JA403162 - Sequence 424 from Patent WO2011080316.
JA405793 - Sequence 424 from Patent EP2336353.
JA429319 - Sequence 424 from Patent WO2011095623.
JA526340 - Sequence 490 from Patent EP2369011.
JA526847 - Sequence 490 from Patent EP2369012.
JA527354 - Sequence 490 from Patent EP2369013.
JA536283 - Sequence 490 from Patent EP2371971.
JA715255 - Sequence 1037 from Patent EP2401406.
JA788288 - Sequence 490 from Patent EP2479285.
JA788786 - Sequence 490 from Patent EP2479286.
JA791838 - Sequence 240 from Patent WO2012089772.
JA791988 - Sequence 37 from Patent WO2012089753.
JA811120 - Sequence 490 from Patent EP2468890.
JA811618 - Sequence 490 from Patent EP2468891.
JA812116 - Sequence 490 from Patent EP2468893.
JA812614 - Sequence 490 from Patent EP2468894.
JA813112 - Sequence 490 from Patent EP2468895.
JA813610 - Sequence 490 from Patent EP2468896.
JA814108 - Sequence 490 from Patent EP2468897.
JA814606 - Sequence 490 from Patent EP2468898.
JA815104 - Sequence 490 from Patent EP2468899.
JA817347 - Sequence 490 from Patent EP2468892.
JA826159 - Sequence 490 from Patent EP2471956.
JA826657 - Sequence 490 from Patent EP2471958.
JB022736 - Sequence 578 from Patent WO2013026685.
JB024944 - Sequence 490 from Patent EP2505668.
JB025442 - Sequence 490 from Patent EP2505669.
JB074813 - Sequence 73 from Patent WO2012168448.
JB079829 - Sequence 490 from Patent EP2487252.
JB080327 - Sequence 490 from Patent EP2487253.
JB080825 - Sequence 490 from Patent EP2487254.
JB081323 - Sequence 490 from Patent EP2487255.
JB081821 - Sequence 490 from Patent EP2487256.
JB082319 - Sequence 490 from Patent EP2487257.
JB082817 - Sequence 490 from Patent EP2487258.
JB083315 - Sequence 490 from Patent EP2487259.
JB083813 - Sequence 490 from Patent EP2487260.
JB084311 - Sequence 490 from Patent EP2487261.
JB084809 - Sequence 490 from Patent EP2487262.
JB085307 - Sequence 490 from Patent EP2487263.
JB087985 - Sequence 490 from Patent EP2502630.
JB148189 - Sequence 490 from Patent EP2484782.
JB148687 - Sequence 490 from Patent EP2484783.
JB153412 - Sequence 490 from Patent EP2514433.
JB153910 - Sequence 490 from Patent EP2514434.
JB158051 - Sequence 39 from Patent WO2012142313.
JB620369 - Sequence 349 from Patent WO2013063544.
JB622499 - Sequence 490 from Patent EP2586454.
JB622997 - Sequence 490 from Patent EP2586455.
JC002060 - Sequence 490 from Patent EP2591794.
JC208201 - Sequence 263 from Patent EP2524033.
JC244559 - Sequence 179 from Patent WO2012020308.
JC334251 - Sequence 169 from Patent EP2487240.
JC504792 - Sequence 19 from Patent WO2014037574.
JC512976 - Sequence 3229 from Patent WO2014113089.
LF160883 - JP 2016513950-A/949: Oligomers with improved off-target profile.
LF404051 - JP 2015509366-A/44: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LP726771 - Sequence 465 from Patent EP2883966.
LP819041 - Sequence 465 from Patent EP3296406.
LP938983 - Sequence 465 from Patent EP3184651.
LQ070564 - Sequence 888 from Patent EP2964234.
LQ104576 - Sequence 19 from Patent EP2919817.
LQ441066 - Sequence 73 from Patent EP3029157.
LY405231 - KR 1020160117535-A/536: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233927 - JP 2017184756-A/319: Oligonucleotides for modulating target RNA activity.
MA260470 - JP 2017505623-A/536: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA353582 - JP 2018075017-A/44: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MS638013 - Sequence 130 from Patent WO2017037190.
MS811004 - Sequence 8 from Patent EP3143123.
MS834278 - Sequence 424 from Patent EP3112479.
MS902105 - Sequence 578 from Patent EP3156505.
FW364258 - Oligonucleotides for modulating target RNA activity.
HI965138 - Sequence 423 from Patent WO2010139812.
HI966143 - Sequence 463 from Patent WO2010139811.
HI967009 - Sequence 463 from Patent WO2010139810.
HV595167 - JP 2010539959-A/548: Micromirs.
HZ074192 - JP 2013535982-A/283: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157724 - JP 2015130862-A/548: Micromirs.
HZ186571 - JP 2015146814-A/320: Oligonucleotides for modulating target RNA activity.
HZ480317 - JP 2015535430-A/823: TERMINALLY MODIFIED RNA.
HZ531295 - JP 2016502527-A/17: miRNAs AS NOVEL THERAPEUTIC ADJUVANTS AND BIOMARKERS FOR THE PROGNOSIS AND TREATMENT OF DRUG RESISTANT BREAST CANCERS.
HZ790248 - JP 2016504050-A/1993: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401176 - Sequence 423 from Patent WO2011080318.
JA402154 - Sequence 423 from Patent WO2011080315.
JA403161 - Sequence 423 from Patent WO2011080316.
JA405792 - Sequence 423 from Patent EP2336353.
JA429318 - Sequence 423 from Patent WO2011095623.
JB022226 - Sequence 68 from Patent WO2013026685.
JB022760 - Sequence 14 from Patent WO2013026684.
JB074788 - Sequence 48 from Patent WO2012168448.
JB620368 - Sequence 348 from Patent WO2013063544.
JC244558 - Sequence 178 from Patent WO2012020308.
JC512980 - Sequence 3233 from Patent WO2014113089.
LF159989 - JP 2016513950-A/55: Oligomers with improved off-target profile.
LP726769 - Sequence 463 from Patent EP2883966.
LP819039 - Sequence 463 from Patent EP3296406.
LP938981 - Sequence 463 from Patent EP3184651.
LQ070568 - Sequence 892 from Patent EP2964234.
LQ104574 - Sequence 17 from Patent EP2919817.
LQ441041 - Sequence 48 from Patent EP3029157.
LY405232 - KR 1020160117535-A/537: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233928 - JP 2017184756-A/320: Oligonucleotides for modulating target RNA activity.
MA260471 - JP 2017505623-A/537: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673211 - Sequence 14 from Patent EP3135774.
MS811005 - Sequence 9 from Patent EP3143123.
MS834277 - Sequence 423 from Patent EP3112479.
MS901595 - Sequence 68 from Patent EP3156505.
DM175374 - A nucleics Acid regulating cell growth.
DM208664 - Efficient Method for Nuclear Reprogramming.
FU261313 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763815 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV527429 - Nucleic acid controling mast cell degranulation.
FW393707 - Efficient Method for Nuclear Reprogramming.
HH933077 - Sequence 289 from Patent EP2239675.
HI208854 - Sequence 58 from Patent EP2041574.
HV304714 - JP 2009531018-A/281: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305212 - JP 2009531019-A/281: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV317132 - JP 2009543862-A/58: CANCER BIOMARKERS AND METHODS OF USE THEREOF.
HV970402 - JP 2012523000-A/289: Method for in vitro Diagnosing a Complex Disease.
HW119421 - JP 2013046612-A/281: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589750 - JP 2013121348-A/281: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW818149 - JP 2015500013-A/76: Expression of miRNAs in placental tissue.
HZ408372 - JP 2015528002-A/969: CHIRAL CONTROL.
HZ413554 - JP 2014060993-A/281: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501765 - JP 2016025853-A/281: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526131 - Sequence 281 from Patent EP2369011.
JA526638 - Sequence 281 from Patent EP2369012.
JA527145 - Sequence 281 from Patent EP2369013.
JA536074 - Sequence 281 from Patent EP2371971.
JA668084 - Sequence 58 from Patent WO2011139721.
JA788079 - Sequence 281 from Patent EP2479285.
JA788577 - Sequence 281 from Patent EP2479286.
JA810911 - Sequence 281 from Patent EP2468890.
JA811409 - Sequence 281 from Patent EP2468891.
JA811907 - Sequence 281 from Patent EP2468893.
JA812405 - Sequence 281 from Patent EP2468894.
JA812903 - Sequence 281 from Patent EP2468895.
JA813401 - Sequence 281 from Patent EP2468896.
JA813899 - Sequence 281 from Patent EP2468897.
JA814397 - Sequence 281 from Patent EP2468898.
JA814895 - Sequence 281 from Patent EP2468899.
JA817138 - Sequence 281 from Patent EP2468892.
JA825950 - Sequence 281 from Patent EP2471956.
JA826448 - Sequence 281 from Patent EP2471958.
JB024735 - Sequence 281 from Patent EP2505668.
JB025233 - Sequence 281 from Patent EP2505669.
JB079620 - Sequence 281 from Patent EP2487252.
JB080118 - Sequence 281 from Patent EP2487253.
JB080616 - Sequence 281 from Patent EP2487254.
JB081114 - Sequence 281 from Patent EP2487255.
JB081612 - Sequence 281 from Patent EP2487256.
JB082110 - Sequence 281 from Patent EP2487257.
JB082608 - Sequence 281 from Patent EP2487258.
JB083106 - Sequence 281 from Patent EP2487259.
JB083604 - Sequence 281 from Patent EP2487260.
JB084102 - Sequence 281 from Patent EP2487261.
JB084600 - Sequence 281 from Patent EP2487262.
JB085098 - Sequence 281 from Patent EP2487263.
JB087776 - Sequence 281 from Patent EP2502630.
JB147980 - Sequence 281 from Patent EP2484782.
JB148478 - Sequence 281 from Patent EP2484783.
JB153203 - Sequence 281 from Patent EP2514433.
JB153701 - Sequence 281 from Patent EP2514434.
JB318090 - Sequence 58 from Patent EP2442108.
JB326497 - Sequence 58 from Patent EP2450710.
JB334430 - Sequence 58 from Patent EP2442109.
JB622290 - Sequence 281 from Patent EP2586454.
JB622788 - Sequence 281 from Patent EP2586455.
JB730454 - Sequence 76 from Patent WO2013079701.
JC001851 - Sequence 281 from Patent EP2591794.
LG051706 - KR 1020150036642-A/972: CHIRAL CONTROL.
LP834192 - Sequence 76 from Patent EP3190186.
CS548388 - Sequence 1418 from Patent EP1777301.
DJ087800 - Novel miRNA molecules isolated from human embryonic stem cell.
DM174430 - A nucleics Acid regulating cell growth.
FU261503 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU764005 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525665 - Nucleic acid controling mast cell degranulation.
FW312129 - DETECTING NUCLEIC ACIDS.
FW364196 - Oligonucleotides for modulating target RNA activity.
HI208855 - Sequence 59 from Patent EP2041574.
HI561021 - Sequence 236 from Patent EP2190992.
HI965206 - Sequence 491 from Patent WO2010139812.
HI966096 - Sequence 416 from Patent WO2010139811.
HI966962 - Sequence 416 from Patent WO2010139810.
HV304904 - JP 2009531018-A/471: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305402 - JP 2009531019-A/471: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV317133 - JP 2009543862-A/59: CANCER BIOMARKERS AND METHODS OF USE THEREOF.
HV492092 - WO 2011087154-A/265: Method For Screening Induced Pluripotent Stem Cells.
HV514194 - WO 2011102444-A/18: METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS.
HV534429 - WO 2011111715-A/945: Nucleic acid for controlling cell cycle.
HV594122 - JP 2010538653-A/236: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595100 - JP 2010539959-A/481: Micromirs.
HV954107 - JP 2012518421-A/1019: METHODS OF DETECTING LUNG CANCER.
HW119611 - JP 2013046612-A/471: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW262296 - JP 2013516982-A/265: Method For Screening Induced Pluripotent Stem Cells.
HW589940 - JP 2013121348-A/471: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW608545 - JP 2014515024-A/34: Micro-RNA Inhibitors and Their Uses in Disease.
HW818150 - JP 2015500013-A/77: Expression of miRNAs in placental tissue.
HZ043382 - JP 2015510401-A/472: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074191 - JP 2013535982-A/282: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082008 - JP 2015514392-A/472: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ083103 - JP 2015513906-A/460: Stem Cell Microparticles.
HZ157657 - JP 2015130862-A/481: Micromirs.
HZ186509 - JP 2015146814-A/258: Oligonucleotides for modulating target RNA activity.
HZ413744 - JP 2014060993-A/471: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ436884 - JP 2015529450-A/460: Stem Cell Microparticles.
HZ480049 - JP 2015535430-A/555: TERMINALLY MODIFIED RNA.
HZ501955 - JP 2016025853-A/471: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ789980 - JP 2016504050-A/1725: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401244 - Sequence 491 from Patent WO2011080318.
JA402222 - Sequence 491 from Patent WO2011080315.
JA403229 - Sequence 491 from Patent WO2011080316.
JA405860 - Sequence 491 from Patent EP2336353.
JA426971 - Sequence 304 from Patent WO2011072177.
JA429386 - Sequence 491 from Patent WO2011095623.
JA526321 - Sequence 471 from Patent EP2369011.
JA526828 - Sequence 471 from Patent EP2369012.
JA527335 - Sequence 471 from Patent EP2369013.
JA536264 - Sequence 471 from Patent EP2371971.
JA668085 - Sequence 59 from Patent WO2011139721.
JA715237 - Sequence 1019 from Patent EP2401406.
JA788269 - Sequence 471 from Patent EP2479285.
JA788767 - Sequence 471 from Patent EP2479286.
JA791893 - Sequence 295 from Patent WO2012089772.
JA811101 - Sequence 471 from Patent EP2468890.
JA811599 - Sequence 471 from Patent EP2468891.
JA812097 - Sequence 471 from Patent EP2468893.
JA812595 - Sequence 471 from Patent EP2468894.
JA813093 - Sequence 471 from Patent EP2468895.
JA813591 - Sequence 471 from Patent EP2468896.
JA814089 - Sequence 471 from Patent EP2468897.
JA814587 - Sequence 471 from Patent EP2468898.
JA815085 - Sequence 471 from Patent EP2468899.
JA817328 - Sequence 471 from Patent EP2468892.
JA826140 - Sequence 471 from Patent EP2471956.
JA826638 - Sequence 471 from Patent EP2471958.
JB022682 - Sequence 524 from Patent WO2013026685.
JB023147 - Sequence 401 from Patent WO2013026684.
JB024925 - Sequence 471 from Patent EP2505668.
JB025423 - Sequence 471 from Patent EP2505669.
JB050078 - Sequence 165 from Patent WO2013020926.
JB079810 - Sequence 471 from Patent EP2487252.
JB080308 - Sequence 471 from Patent EP2487253.
JB080806 - Sequence 471 from Patent EP2487254.
JB081304 - Sequence 471 from Patent EP2487255.
JB081802 - Sequence 471 from Patent EP2487256.
JB082300 - Sequence 471 from Patent EP2487257.
JB082798 - Sequence 471 from Patent EP2487258.
JB083296 - Sequence 471 from Patent EP2487259.
JB083794 - Sequence 471 from Patent EP2487260.
JB084292 - Sequence 471 from Patent EP2487261.
JB084790 - Sequence 471 from Patent EP2487262.
JB085288 - Sequence 471 from Patent EP2487263.
JB087966 - Sequence 471 from Patent EP2502630.
JB148170 - Sequence 471 from Patent EP2484782.
JB148668 - Sequence 471 from Patent EP2484783.
JB153393 - Sequence 471 from Patent EP2514433.
JB153891 - Sequence 471 from Patent EP2514434.
JB158046 - Sequence 34 from Patent WO2012142313.
JB175351 - Sequence 383 from Patent WO2012101219.
JB318091 - Sequence 59 from Patent EP2442108.
JB326498 - Sequence 59 from Patent EP2450710.
JB334431 - Sequence 59 from Patent EP2442109.
JB620367 - Sequence 347 from Patent WO2013063544.
JB622480 - Sequence 471 from Patent EP2586454.
JB622978 - Sequence 471 from Patent EP2586455.
JB624416 - Sequence 236 from Patent EP2610342.
JB730455 - Sequence 77 from Patent WO2013079701.
JB835712 - Sequence 2 from Patent WO2013057567.
JC002041 - Sequence 471 from Patent EP2591794.
JC017582 - Sequence 20 from Patent WO2013093870.
JC037666 - Sequence 194 from Patent EP2643479.
JC172088 - Sequence 460 from Patent WO2013150303.
JC208203 - Sequence 265 from Patent EP2524033.
JC334218 - Sequence 136 from Patent EP2487240.
JC504793 - Sequence 20 from Patent WO2014037574.
JC512712 - Sequence 2965 from Patent WO2014113089.
JC572899 - Sequence 460 from Patent WO2014125276.
JC582587 - Sequence 460 from Patent WO2014125277.
JE954283 - Sequence 460 from Patent WO2015052526.
JE956036 - Sequence 460 from Patent WO2015052527.
LF137788 - JP 2016507550-A/460: Method of Producing Microparticles.
LF161972 - JP 2016513950-A/2038: Oligomers with improved off-target profile.
LF162753 - JP 2016513095-A/460: Stem Cell Microparticles and miRNA.
LF401876 - JP 2015502976-A/20: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LF953505 - JP 2016534103-A/460: Stem Cell Microparticles and miRNA.
LG005850 - KR 1020150004822-A/460: STEM CELL MICROPARTICLES.
LG053546 - KR 1020150059168-A/460: STEM CELL MICROPARTICLES.
LG240785 - KR 1020160035087-A/460: STEM CELL MICROPARTICLES AND MIRNA.
LP726722 - Sequence 416 from Patent EP2883966.
LP818992 - Sequence 416 from Patent EP3296406.
LP834193 - Sequence 77 from Patent EP3190186.
LP938934 - Sequence 416 from Patent EP3184651.
LQ070300 - Sequence 624 from Patent EP2964234.
LV470870 - JP 2016534036-A/460: Stem Cell Microparticles and miRNA.
LY405165 - KR 1020160117535-A/470: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ231633 - JP 2017186339-A/20: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LZ233866 - JP 2017184756-A/258: Oligonucleotides for modulating target RNA activity.
MA260404 - JP 2017505623-A/470: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673598 - Sequence 401 from Patent EP3135774.
MS811003 - Sequence 7 from Patent EP3143123.
MS833531 - Sequence 236 from Patent EP3112464.
MS834345 - Sequence 491 from Patent EP3112479.
MS902051 - Sequence 524 from Patent EP3156505.
DM175320 - A nucleics Acid regulating cell growth.
FV525781 - Nucleic acid controling mast cell degranulation.
FW364197 - Oligonucleotides for modulating target RNA activity.
HI561022 - Sequence 237 from Patent EP2190992.
HI965205 - Sequence 490 from Patent WO2010139812.
HI966326 - Sequence 646 from Patent WO2010139811.
HI967192 - Sequence 646 from Patent WO2010139810.
HV594123 - JP 2010538653-A/237: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595101 - JP 2010539959-A/482: Micromirs.
HW818151 - JP 2015500013-A/78: Expression of miRNAs in placental tissue.
HZ074190 - JP 2013535982-A/281: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157658 - JP 2015130862-A/482: Micromirs.
HZ186510 - JP 2015146814-A/259: Oligonucleotides for modulating target RNA activity.
HZ480050 - JP 2015535430-A/556: TERMINALLY MODIFIED RNA.
HZ789981 - JP 2016504050-A/1726: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401243 - Sequence 490 from Patent WO2011080318.
JA402221 - Sequence 490 from Patent WO2011080315.
JA403228 - Sequence 490 from Patent WO2011080316.
JA405859 - Sequence 490 from Patent EP2336353.
JA426700 - Sequence 33 from Patent WO2011072177.
JA429385 - Sequence 490 from Patent WO2011095623.
JB620366 - Sequence 346 from Patent WO2013063544.
JB624417 - Sequence 237 from Patent EP2610342.
JB730456 - Sequence 78 from Patent WO2013079701.
JC512713 - Sequence 2966 from Patent WO2014113089.
LF161431 - JP 2016513950-A/1497: Oligomers with improved off-target profile.
LP726952 - Sequence 646 from Patent EP2883966.
LP819222 - Sequence 646 from Patent EP3296406.
LP834194 - Sequence 78 from Patent EP3190186.
LP939164 - Sequence 646 from Patent EP3184651.
LQ070301 - Sequence 625 from Patent EP2964234.
LY405166 - KR 1020160117535-A/471: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233867 - JP 2017184756-A/259: Oligonucleotides for modulating target RNA activity.
MA260405 - JP 2017505623-A/471: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS833532 - Sequence 237 from Patent EP3112464.
MS834344 - Sequence 490 from Patent EP3112479.
CS266485 - Sequence 177 from Patent WO2005118806.
CS266681 - Sequence 373 from Patent WO2005118806.
DL076647 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DL076843 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004297 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM004493 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM175417 - A nucleics Acid regulating cell growth.
DM208663 - Efficient Method for Nuclear Reprogramming.
FU261310 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763812 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV527428 - Nucleic acid controling mast cell degranulation.
FW393706 - Efficient Method for Nuclear Reprogramming.
FW421639 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421835 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304711 - JP 2009531018-A/278: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305209 - JP 2009531019-A/278: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119418 - JP 2013046612-A/278: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367510 - JP 2012228254-A/177: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367706 - JP 2012228254-A/373: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411903 - JP 2014000079-A/177: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW412099 - JP 2014000079-A/373: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589747 - JP 2013121348-A/278: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674249 - JP 2014217381-A/177: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW674445 - JP 2014217381-A/373: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW818140 - JP 2015500013-A/67: Expression of miRNAs in placental tissue.
HZ067191 - JP 2014012020-A/177: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067387 - JP 2014012020-A/373: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ408369 - JP 2015528002-A/966: CHIRAL CONTROL.
HZ413551 - JP 2014060993-A/278: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427615 - JP 2014217384-A/177: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427811 - JP 2014217384-A/373: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428418 - JP 2014217385-A/177: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428614 - JP 2014217385-A/373: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429221 - JP 2014217386-A/177: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429417 - JP 2014217386-A/373: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430024 - JP 2014217387-A/177: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430220 - JP 2014217387-A/373: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501762 - JP 2016025853-A/278: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769281 - JP 2014223080-A/177: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769477 - JP 2014223080-A/373: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058675 - Sequence 177 from Patent EP2298893.
JA058871 - Sequence 373 from Patent EP2298893.
JA059478 - Sequence 177 from Patent EP2298894.
JA059674 - Sequence 373 from Patent EP2298894.
JA073801 - Sequence 177 from Patent EP2281887.
JA073997 - Sequence 373 from Patent EP2281887.
JA104938 - Sequence 177 from Patent EP2302051.
JA105134 - Sequence 373 from Patent EP2302051.
JA106278 - Sequence 177 from Patent EP2302052.
JA106474 - Sequence 373 from Patent EP2302052.
JA107081 - Sequence 177 from Patent EP2302053.
JA107277 - Sequence 373 from Patent EP2302053.
JA107884 - Sequence 177 from Patent EP2302054.
JA108080 - Sequence 373 from Patent EP2302054.
JA108687 - Sequence 177 from Patent EP2302055.
JA108883 - Sequence 373 from Patent EP2302055.
JA109490 - Sequence 177 from Patent EP2302056.
JA109686 - Sequence 373 from Patent EP2302056.
JA192006 - Sequence 177 from Patent EP2290066.
JA192202 - Sequence 373 from Patent EP2290066.
JA192905 - Sequence 177 from Patent EP2290067.
JA193101 - Sequence 373 from Patent EP2290067.
JA193804 - Sequence 177 from Patent EP2290068.
JA194000 - Sequence 373 from Patent EP2290068.
JA194703 - Sequence 177 from Patent EP2290069.
JA194899 - Sequence 373 from Patent EP2290069.
JA195602 - Sequence 177 from Patent EP2290070.
JA195798 - Sequence 373 from Patent EP2290070.
JA196501 - Sequence 177 from Patent EP2290071.
JA196697 - Sequence 373 from Patent EP2290071.
JA197400 - Sequence 177 from Patent EP2290072.
JA197596 - Sequence 373 from Patent EP2290072.
JA198299 - Sequence 177 from Patent EP2290073.
JA198495 - Sequence 373 from Patent EP2290073.
JA199198 - Sequence 177 from Patent EP2290074.
JA199394 - Sequence 373 from Patent EP2290074.
JA200097 - Sequence 177 from Patent EP2290075.
JA200293 - Sequence 373 from Patent EP2290075.
JA200996 - Sequence 177 from Patent EP2290076.
JA201192 - Sequence 373 from Patent EP2290076.
JA218118 - Sequence 177 from Patent EP2281888.
JA218314 - Sequence 373 from Patent EP2281888.
JA226269 - Sequence 177 from Patent EP2292755.
JA226465 - Sequence 373 from Patent EP2292755.
JA229124 - Sequence 177 from Patent EP2292756.
JA229320 - Sequence 373 from Patent EP2292756.
JA257395 - Sequence 177 from Patent EP2284265.
JA257591 - Sequence 373 from Patent EP2284265.
JA278675 - Sequence 177 from Patent EP2281886.
JA278871 - Sequence 373 from Patent EP2281886.
JA284561 - Sequence 177 from Patent EP2281889.
JA284757 - Sequence 373 from Patent EP2281889.
JA292614 - Sequence 177 from Patent EP2287303.
JA292810 - Sequence 373 from Patent EP2287303.
JA317800 - Sequence 177 from Patent EP2314688.
JA317996 - Sequence 373 from Patent EP2314688.
JA374859 - Sequence 177 from Patent EP2322616.
JA375055 - Sequence 373 from Patent EP2322616.
JA526128 - Sequence 278 from Patent EP2369011.
JA526635 - Sequence 278 from Patent EP2369012.
JA527142 - Sequence 278 from Patent EP2369013.
JA536071 - Sequence 278 from Patent EP2371971.
JA788076 - Sequence 278 from Patent EP2479285.
JA788574 - Sequence 278 from Patent EP2479286.
JA810908 - Sequence 278 from Patent EP2468890.
JA811406 - Sequence 278 from Patent EP2468891.
JA811904 - Sequence 278 from Patent EP2468893.
JA812402 - Sequence 278 from Patent EP2468894.
JA812900 - Sequence 278 from Patent EP2468895.
JA813398 - Sequence 278 from Patent EP2468896.
JA813896 - Sequence 278 from Patent EP2468897.
JA814394 - Sequence 278 from Patent EP2468898.
JA814892 - Sequence 278 from Patent EP2468899.
JA817135 - Sequence 278 from Patent EP2468892.
JA825947 - Sequence 278 from Patent EP2471956.
JA826445 - Sequence 278 from Patent EP2471958.
JB024732 - Sequence 278 from Patent EP2505668.
JB025230 - Sequence 278 from Patent EP2505669.
JB079617 - Sequence 278 from Patent EP2487252.
JB080115 - Sequence 278 from Patent EP2487253.
JB080613 - Sequence 278 from Patent EP2487254.
JB081111 - Sequence 278 from Patent EP2487255.
JB081609 - Sequence 278 from Patent EP2487256.
JB082107 - Sequence 278 from Patent EP2487257.
JB082605 - Sequence 278 from Patent EP2487258.
JB083103 - Sequence 278 from Patent EP2487259.
JB083601 - Sequence 278 from Patent EP2487260.
JB084099 - Sequence 278 from Patent EP2487261.
JB084597 - Sequence 278 from Patent EP2487262.
JB085095 - Sequence 278 from Patent EP2487263.
JB087773 - Sequence 278 from Patent EP2502630.
JB147977 - Sequence 278 from Patent EP2484782.
JB148475 - Sequence 278 from Patent EP2484783.
JB153200 - Sequence 278 from Patent EP2514433.
JB153698 - Sequence 278 from Patent EP2514434.
JB622287 - Sequence 278 from Patent EP2586454.
JB622785 - Sequence 278 from Patent EP2586455.
JB730445 - Sequence 67 from Patent WO2013079701.
JC001848 - Sequence 278 from Patent EP2591794.
JC221702 - Sequence 177 from Patent EP2471923.
JC221898 - Sequence 373 from Patent EP2471923.
JC268268 - Sequence 177 from Patent EP2471924.
JC268464 - Sequence 373 from Patent EP2471924.
JC340576 - Sequence 177 from Patent EP2471922.
JC340772 - Sequence 373 from Patent EP2471922.
JC469822 - Sequence 177 from Patent EP2471921.
JC470018 - Sequence 373 from Patent EP2471921.
JC735199 - Sequence 4 from Patent WO2014106011.
JC990611 - Sequence 177 from Patent EP2808390.
JC990807 - Sequence 373 from Patent EP2808390.
LF714714 - JP 2016165292-A/177: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF714910 - JP 2016165292-A/373: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856648 - JP 2015142597-A/177: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LF856844 - JP 2015142597-A/373: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051703 - KR 1020150036642-A/969: CHIRAL CONTROL.
LP834183 - Sequence 67 from Patent EP3190186.
CS548385 - Sequence 1415 from Patent EP1777301.
DJ087812 - Novel miRNA molecules isolated from human embryonic stem cell.
DM175269 - A nucleics Acid regulating cell growth.
FU261498 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU764000 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525662 - Nucleic acid controling mast cell degranulation.
FW312123 - DETECTING NUCLEIC ACIDS.
FW364190 - Oligonucleotides for modulating target RNA activity.
HI561015 - Sequence 230 from Patent EP2190992.
HI965212 - Sequence 497 from Patent WO2010139812.
HI966117 - Sequence 437 from Patent WO2010139811.
HI966983 - Sequence 437 from Patent WO2010139810.
HV304899 - JP 2009531018-A/466: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305397 - JP 2009531019-A/466: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV492095 - WO 2011087154-A/268: Method For Screening Induced Pluripotent Stem Cells.
HV514191 - WO 2011102444-A/15: METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS.
HV593843 - JP 2010538610-A/56: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV594116 - JP 2010538653-A/230: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595094 - JP 2010539959-A/475: Micromirs.
HV954102 - JP 2012518421-A/1014: METHODS OF DETECTING LUNG CANCER.
HW119606 - JP 2013046612-A/466: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW262299 - JP 2013516982-A/268: Method For Screening Induced Pluripotent Stem Cells.
HW523295 - JP 2014507123-A/80: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS.
HW589935 - JP 2013121348-A/466: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW608542 - JP 2014515024-A/31: Micro-RNA Inhibitors and Their Uses in Disease.
HW669801 - JP 2013537538-A/532: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW818141 - JP 2015500013-A/68: Expression of miRNAs in placental tissue.
HZ074160 - JP 2013535982-A/251: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083146 - JP 2015513906-A/503: Stem Cell Microparticles.
HZ157651 - JP 2015130862-A/475: Micromirs.
HZ186503 - JP 2015146814-A/252: Oligonucleotides for modulating target RNA activity.
HZ413739 - JP 2014060993-A/466: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ436927 - JP 2015529450-A/503: Stem Cell Microparticles.
HZ480043 - JP 2015535430-A/549: TERMINALLY MODIFIED RNA.
HZ501950 - JP 2016025853-A/466: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ789974 - JP 2016504050-A/1719: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401250 - Sequence 497 from Patent WO2011080318.
JA402228 - Sequence 497 from Patent WO2011080315.
JA403235 - Sequence 497 from Patent WO2011080316.
JA405866 - Sequence 497 from Patent EP2336353.
JA426822 - Sequence 155 from Patent WO2011072177.
JA429392 - Sequence 497 from Patent WO2011095623.
JA526316 - Sequence 466 from Patent EP2369011.
JA526823 - Sequence 466 from Patent EP2369012.
JA527330 - Sequence 466 from Patent EP2369013.
JA536259 - Sequence 466 from Patent EP2371971.
JA715232 - Sequence 1014 from Patent EP2401406.
JA788264 - Sequence 466 from Patent EP2479285.
JA788762 - Sequence 466 from Patent EP2479286.
JA792160 - Sequence 209 from Patent WO2012089753.
JA811096 - Sequence 466 from Patent EP2468890.
JA811594 - Sequence 466 from Patent EP2468891.
JA812092 - Sequence 466 from Patent EP2468893.
JA812590 - Sequence 466 from Patent EP2468894.
JA813088 - Sequence 466 from Patent EP2468895.
JA813586 - Sequence 466 from Patent EP2468896.
JA814084 - Sequence 466 from Patent EP2468897.
JA814582 - Sequence 466 from Patent EP2468898.
JA815080 - Sequence 466 from Patent EP2468899.
JA817323 - Sequence 466 from Patent EP2468892.
JA826135 - Sequence 466 from Patent EP2471956.
JA826633 - Sequence 466 from Patent EP2471958.
JA885450 - Sequence 80 from Patent WO2012083004.
JB022438 - Sequence 280 from Patent WO2013026685.
JB022864 - Sequence 118 from Patent WO2013026684.
JB024920 - Sequence 466 from Patent EP2505668.
JB025418 - Sequence 466 from Patent EP2505669.
JB079805 - Sequence 466 from Patent EP2487252.
JB080303 - Sequence 466 from Patent EP2487253.
JB080801 - Sequence 466 from Patent EP2487254.
JB081299 - Sequence 466 from Patent EP2487255.
JB081797 - Sequence 466 from Patent EP2487256.
JB082295 - Sequence 466 from Patent EP2487257.
JB082793 - Sequence 466 from Patent EP2487258.
JB083291 - Sequence 466 from Patent EP2487259.
JB083789 - Sequence 466 from Patent EP2487260.
JB084287 - Sequence 466 from Patent EP2487261.
JB084785 - Sequence 466 from Patent EP2487262.
JB085283 - Sequence 466 from Patent EP2487263.
JB087961 - Sequence 466 from Patent EP2502630.
JB148165 - Sequence 466 from Patent EP2484782.
JB148663 - Sequence 466 from Patent EP2484783.
JB153388 - Sequence 466 from Patent EP2514433.
JB153886 - Sequence 466 from Patent EP2514434.
JB158043 - Sequence 31 from Patent WO2012142313.
JB175275 - Sequence 307 from Patent WO2012101219.
JB620336 - Sequence 316 from Patent WO2013063544.
JB622475 - Sequence 466 from Patent EP2586454.
JB622973 - Sequence 466 from Patent EP2586455.
JB624410 - Sequence 230 from Patent EP2610342.
JB730446 - Sequence 68 from Patent WO2013079701.
JC002036 - Sequence 466 from Patent EP2591794.
JC017578 - Sequence 16 from Patent WO2013093870.
JC037664 - Sequence 192 from Patent EP2643479.
JC172131 - Sequence 503 from Patent WO2013150303.
JC208206 - Sequence 268 from Patent EP2524033.
JC270141 - Sequence 532 from Patent WO2012020307.
JC334213 - Sequence 131 from Patent EP2487240.
JC504796 - Sequence 23 from Patent WO2014037574.
JC512706 - Sequence 2959 from Patent WO2014113089.
JC572942 - Sequence 503 from Patent WO2014125276.
JC582630 - Sequence 503 from Patent WO2014125277.
JE954326 - Sequence 503 from Patent WO2015052526.
JE956079 - Sequence 503 from Patent WO2015052527.
LF137831 - JP 2016507550-A/503: Method of Producing Microparticles.
LF160558 - JP 2016513950-A/624: Oligomers with improved off-target profile.
LF162796 - JP 2016513095-A/503: Stem Cell Microparticles and miRNA.
LF401872 - JP 2015502976-A/16: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LF857607 - JP 2015130879-A/56: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LF953548 - JP 2016534103-A/503: Stem Cell Microparticles and miRNA.
LG005893 - KR 1020150004822-A/503: STEM CELL MICROPARTICLES.
LG053589 - KR 1020150059168-A/503: STEM CELL MICROPARTICLES.
LG240828 - KR 1020160035087-A/503: STEM CELL MICROPARTICLES AND MIRNA.
LP726743 - Sequence 437 from Patent EP2883966.
LP819013 - Sequence 437 from Patent EP3296406.
LP834184 - Sequence 68 from Patent EP3190186.
LP938955 - Sequence 437 from Patent EP3184651.
LQ070294 - Sequence 618 from Patent EP2964234.
LQ500642 - Sequence 56 from Patent EP3048177.
LV470913 - JP 2016534036-A/503: Stem Cell Microparticles and miRNA.
LX270598 - JP 2016056210-A/532: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY405159 - KR 1020160117535-A/464: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ231629 - JP 2017186339-A/16: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LZ233860 - JP 2017184756-A/252: Oligonucleotides for modulating target RNA activity.
MA260398 - JP 2017505623-A/464: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673315 - Sequence 118 from Patent EP3135774.
MS833525 - Sequence 230 from Patent EP3112464.
MS834351 - Sequence 497 from Patent EP3112479.
MS901807 - Sequence 280 from Patent EP3156505.
MS904140 - Sequence 56 from Patent EP3138926.
HH981307 - Sequence 67 from Patent EP1723162.
JB256148 - Sequence 67 from Patent EP2327710.
CS548382 - Sequence 1412 from Patent EP1777301.
DJ087799 - Novel miRNA molecules isolated from human embryonic stem cell.
DM174471 - A nucleics Acid regulating cell growth.
FW312124 - DETECTING NUCLEIC ACIDS.
MS811002 - Sequence 6 from Patent EP3143123.
FW364191 - Oligonucleotides for modulating target RNA activity.
HI561016 - Sequence 231 from Patent EP2190992.
HI965211 - Sequence 496 from Patent WO2010139812.
HI966016 - Sequence 336 from Patent WO2010139811.
HI966882 - Sequence 336 from Patent WO2010139810.
HV492089 - WO 2011087154-A/262: Method For Screening Induced Pluripotent Stem Cells.
HV594117 - JP 2010538653-A/231: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595095 - JP 2010539959-A/476: Micromirs.
HW262293 - JP 2013516982-A/262: Method For Screening Induced Pluripotent Stem Cells.
HW818142 - JP 2015500013-A/69: Expression of miRNAs in placental tissue.
HZ043380 - JP 2015510401-A/470: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074159 - JP 2013535982-A/250: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082006 - JP 2015514392-A/470: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ083154 - JP 2015513906-A/511: Stem Cell Microparticles.
HZ157652 - JP 2015130862-A/476: Micromirs.
HZ186504 - JP 2015146814-A/253: Oligonucleotides for modulating target RNA activity.
HZ436935 - JP 2015529450-A/511: Stem Cell Microparticles.
HZ480044 - JP 2015535430-A/550: TERMINALLY MODIFIED RNA.
HZ789975 - JP 2016504050-A/1720: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401249 - Sequence 496 from Patent WO2011080318.
JA402227 - Sequence 496 from Patent WO2011080315.
JA403234 - Sequence 496 from Patent WO2011080316.
JA405865 - Sequence 496 from Patent EP2336353.
JA427348 - Sequence 681 from Patent WO2011072177.
JA429391 - Sequence 496 from Patent WO2011095623.
JA792005 - Sequence 54 from Patent WO2012089753.
JB175245 - Sequence 277 from Patent WO2012101219.
JB620335 - Sequence 315 from Patent WO2013063544.
JB624411 - Sequence 231 from Patent EP2610342.
JB730447 - Sequence 69 from Patent WO2013079701.
JC037665 - Sequence 193 from Patent EP2643479.
JC172139 - Sequence 511 from Patent WO2013150303.
JC208200 - Sequence 262 from Patent EP2524033.
JC512707 - Sequence 2960 from Patent WO2014113089.
JC572950 - Sequence 511 from Patent WO2014125276.
JC582638 - Sequence 511 from Patent WO2014125277.
JE954334 - Sequence 511 from Patent WO2015052526.
JE956087 - Sequence 511 from Patent WO2015052527.
LF137839 - JP 2016507550-A/511: Method of Producing Microparticles.
LF160169 - JP 2016513950-A/235: Oligomers with improved off-target profile.
LF162804 - JP 2016513095-A/511: Stem Cell Microparticles and miRNA.
LF953556 - JP 2016534103-A/511: Stem Cell Microparticles and miRNA.
LG005901 - KR 1020150004822-A/511: STEM CELL MICROPARTICLES.
LG053597 - KR 1020150059168-A/511: STEM CELL MICROPARTICLES.
LG240836 - KR 1020160035087-A/511: STEM CELL MICROPARTICLES AND MIRNA.
LP726642 - Sequence 336 from Patent EP2883966.
LP818912 - Sequence 336 from Patent EP3296406.
LP834185 - Sequence 69 from Patent EP3190186.
LP938854 - Sequence 336 from Patent EP3184651.
LQ070295 - Sequence 619 from Patent EP2964234.
LQ278518 - Sequence 57 from Patent WO2016066288.
LV470921 - JP 2016534036-A/511: Stem Cell Microparticles and miRNA.
LY405160 - KR 1020160117535-A/465: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233861 - JP 2017184756-A/253: Oligonucleotides for modulating target RNA activity.
MA260399 - JP 2017505623-A/465: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS833526 - Sequence 231 from Patent EP3112464.
MS834350 - Sequence 496 from Patent EP3112479.
DI443570 - KR 1020140074997-A/191: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DM176315 - A nucleics Acid regulating cell growth.
DM208662 - Efficient Method for Nuclear Reprogramming.
FU261312 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763814 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525926 - Nucleic acid controling mast cell degranulation.
FW393705 - Efficient Method for Nuclear Reprogramming.
HH826051 - Sequence 4 from Patent WO2010100328.
HV304713 - JP 2009531018-A/280: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305211 - JP 2009531019-A/280: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119420 - JP 2013046612-A/280: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589749 - JP 2013121348-A/280: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW807896 - JP 2014534810-A/191: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW818146 - JP 2015500013-A/73: Expression of miRNAs in placental tissue.
HZ408371 - JP 2015528002-A/968: CHIRAL CONTROL.
HZ413553 - JP 2014060993-A/280: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501764 - JP 2016025853-A/280: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526130 - Sequence 280 from Patent EP2369011.
JA526637 - Sequence 280 from Patent EP2369012.
JA527144 - Sequence 280 from Patent EP2369013.
JA536073 - Sequence 280 from Patent EP2371971.
JA788078 - Sequence 280 from Patent EP2479285.
JA788576 - Sequence 280 from Patent EP2479286.
JA810910 - Sequence 280 from Patent EP2468890.
JA811408 - Sequence 280 from Patent EP2468891.
JA811906 - Sequence 280 from Patent EP2468893.
JA812404 - Sequence 280 from Patent EP2468894.
JA812902 - Sequence 280 from Patent EP2468895.
JA813400 - Sequence 280 from Patent EP2468896.
JA813898 - Sequence 280 from Patent EP2468897.
JA814396 - Sequence 280 from Patent EP2468898.
JA814894 - Sequence 280 from Patent EP2468899.
JA817137 - Sequence 280 from Patent EP2468892.
JA825949 - Sequence 280 from Patent EP2471956.
JA826447 - Sequence 280 from Patent EP2471958.
JB024734 - Sequence 280 from Patent EP2505668.
JB025232 - Sequence 280 from Patent EP2505669.
JB079619 - Sequence 280 from Patent EP2487252.
JB080117 - Sequence 280 from Patent EP2487253.
JB080615 - Sequence 280 from Patent EP2487254.
JB081113 - Sequence 280 from Patent EP2487255.
JB081611 - Sequence 280 from Patent EP2487256.
JB082109 - Sequence 280 from Patent EP2487257.
JB082607 - Sequence 280 from Patent EP2487258.
JB083105 - Sequence 280 from Patent EP2487259.
JB083603 - Sequence 280 from Patent EP2487260.
JB084101 - Sequence 280 from Patent EP2487261.
JB084599 - Sequence 280 from Patent EP2487262.
JB085097 - Sequence 280 from Patent EP2487263.
JB087775 - Sequence 280 from Patent EP2502630.
JB147979 - Sequence 280 from Patent EP2484782.
JB148477 - Sequence 280 from Patent EP2484783.
JB153202 - Sequence 280 from Patent EP2514433.
JB153700 - Sequence 280 from Patent EP2514434.
JB622289 - Sequence 280 from Patent EP2586454.
JB622787 - Sequence 280 from Patent EP2586455.
JB730451 - Sequence 73 from Patent WO2013079701.
JC001850 - Sequence 280 from Patent EP2591794.
LG051705 - KR 1020150036642-A/971: CHIRAL CONTROL.
LP834189 - Sequence 73 from Patent EP3190186.
HI979112 - Sequence 39 from Patent EP2234483.
HV342494 - JP 2011510623-A/39: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
CS548387 - Sequence 1417 from Patent EP1777301.
DI443569 - KR 1020140074997-A/190: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DJ087798 - Novel miRNA molecules isolated from human embryonic stem cell.
DM175271 - A nucleics Acid regulating cell growth.
FU261502 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU764004 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525664 - Nucleic acid controling mast cell degranulation.
FW312127 - DETECTING NUCLEIC ACIDS.
FW364194 - Oligonucleotides for modulating target RNA activity.
HH826074 - Sequence 27 from Patent WO2010100328.
HI561019 - Sequence 234 from Patent EP2190992.
HI581322 - Sequence 4 from Patent WO2010111631.
HI965208 - Sequence 493 from Patent WO2010139812.
HI965928 - Sequence 248 from Patent WO2010139811.
HI966794 - Sequence 248 from Patent WO2010139810.
HV304903 - JP 2009531018-A/470: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305401 - JP 2009531019-A/470: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV492091 - WO 2011087154-A/264: Method For Screening Induced Pluripotent Stem Cells.
HV514193 - WO 2011102444-A/17: METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS.
HV593831 - JP 2010538610-A/44: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV594120 - JP 2010538653-A/234: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595098 - JP 2010539959-A/479: Micromirs.
HV954106 - JP 2012518421-A/1018: METHODS OF DETECTING LUNG CANCER.
HW119610 - JP 2013046612-A/470: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW262295 - JP 2013516982-A/264: Method For Screening Induced Pluripotent Stem Cells.
HW589939 - JP 2013121348-A/470: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW608544 - JP 2014515024-A/33: Micro-RNA Inhibitors and Their Uses in Disease.
HW807895 - JP 2014534810-A/190: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW818147 - JP 2015500013-A/74: Expression of miRNAs in placental tissue.
HZ074189 - JP 2013535982-A/280: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157655 - JP 2015130862-A/479: Micromirs.
HZ186507 - JP 2015146814-A/256: Oligonucleotides for modulating target RNA activity.
HZ413743 - JP 2014060993-A/470: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ480047 - JP 2015535430-A/553: TERMINALLY MODIFIED RNA.
HZ501954 - JP 2016025853-A/470: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ789978 - JP 2016504050-A/1723: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401246 - Sequence 493 from Patent WO2011080318.
JA402224 - Sequence 493 from Patent WO2011080315.
JA403231 - Sequence 493 from Patent WO2011080316.
JA405862 - Sequence 493 from Patent EP2336353.
JA427063 - Sequence 396 from Patent WO2011072177.
JA429388 - Sequence 493 from Patent WO2011095623.
JA526320 - Sequence 470 from Patent EP2369011.
JA526827 - Sequence 470 from Patent EP2369012.
JA527334 - Sequence 470 from Patent EP2369013.
JA536263 - Sequence 470 from Patent EP2371971.
JA715236 - Sequence 1018 from Patent EP2401406.
JA788268 - Sequence 470 from Patent EP2479285.
JA788766 - Sequence 470 from Patent EP2479286.
JA811100 - Sequence 470 from Patent EP2468890.
JA811598 - Sequence 470 from Patent EP2468891.
JA812096 - Sequence 470 from Patent EP2468893.
JA812594 - Sequence 470 from Patent EP2468894.
JA813092 - Sequence 470 from Patent EP2468895.
JA813590 - Sequence 470 from Patent EP2468896.
JA814088 - Sequence 470 from Patent EP2468897.
JA814586 - Sequence 470 from Patent EP2468898.
JA815084 - Sequence 470 from Patent EP2468899.
JA817327 - Sequence 470 from Patent EP2468892.
JA826139 - Sequence 470 from Patent EP2471956.
JA826637 - Sequence 470 from Patent EP2471958.
JB024924 - Sequence 470 from Patent EP2505668.
JB025422 - Sequence 470 from Patent EP2505669.
JB079809 - Sequence 470 from Patent EP2487252.
JB080307 - Sequence 470 from Patent EP2487253.
JB080805 - Sequence 470 from Patent EP2487254.
JB081303 - Sequence 470 from Patent EP2487255.
JB081801 - Sequence 470 from Patent EP2487256.
JB082299 - Sequence 470 from Patent EP2487257.
JB082797 - Sequence 470 from Patent EP2487258.
JB083295 - Sequence 470 from Patent EP2487259.
JB083793 - Sequence 470 from Patent EP2487260.
JB084291 - Sequence 470 from Patent EP2487261.
JB084789 - Sequence 470 from Patent EP2487262.
JB085287 - Sequence 470 from Patent EP2487263.
JB087965 - Sequence 470 from Patent EP2502630.
JB148169 - Sequence 470 from Patent EP2484782.
JB148667 - Sequence 470 from Patent EP2484783.
JB153392 - Sequence 470 from Patent EP2514433.
JB153890 - Sequence 470 from Patent EP2514434.
JB158045 - Sequence 33 from Patent WO2012142313.
JB620365 - Sequence 345 from Patent WO2013063544.
JB622479 - Sequence 470 from Patent EP2586454.
JB622977 - Sequence 470 from Patent EP2586455.
JB624414 - Sequence 234 from Patent EP2610342.
JB730452 - Sequence 74 from Patent WO2013079701.
JC002040 - Sequence 470 from Patent EP2591794.
JC017580 - Sequence 18 from Patent WO2013093870.
JC208202 - Sequence 264 from Patent EP2524033.
JC334216 - Sequence 134 from Patent EP2487240.
JC504794 - Sequence 21 from Patent WO2014037574.
JC512710 - Sequence 2963 from Patent WO2014113089.
LF161576 - JP 2016513950-A/1642: Oligomers with improved off-target profile.
LF401874 - JP 2015502976-A/18: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LF857595 - JP 2015130879-A/44: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LG097347 - KR 1020150088336-A/4: TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS.
LP726554 - Sequence 248 from Patent EP2883966.
LP818824 - Sequence 248 from Patent EP3296406.
LP834190 - Sequence 74 from Patent EP3190186.
LP938766 - Sequence 248 from Patent EP3184651.
LQ070298 - Sequence 622 from Patent EP2964234.
LQ500630 - Sequence 44 from Patent EP3048177.
LX281032 - JP 2016506968-A/4: NATURAL KILLER CELLS FROM PLACENTA.
LY396015 - KR 1020160098527-A/4: TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS.
LY405163 - KR 1020160117535-A/468: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY536445 - KR 1020170107586-A/4: TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS.
LZ231631 - JP 2017186339-A/18: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LZ233864 - JP 2017184756-A/256: Oligonucleotides for modulating target RNA activity.
MA158786 - JP 2016216472-A/4: TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS.
MA260402 - JP 2017505623-A/468: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS810999 - Sequence 3 from Patent EP3143123.
MS833529 - Sequence 234 from Patent EP3112464.
MS834347 - Sequence 493 from Patent EP3112479.
MS904128 - Sequence 44 from Patent EP3138926.
CS548384 - Sequence 1414 from Patent EP1777301.
DJ087797 - Novel miRNA molecules isolated from human embryonic stem cell.
FU261501 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU764003 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV524370 - Nucleic acid controling mast cell degranulation.
FW312128 - DETECTING NUCLEIC ACIDS.
FW364195 - Oligonucleotides for modulating target RNA activity.
HI561020 - Sequence 235 from Patent EP2190992.
HI965207 - Sequence 492 from Patent WO2010139812.
HI966478 - Sequence 798 from Patent WO2010139811.
HI967344 - Sequence 798 from Patent WO2010139810.
HI979087 - Sequence 14 from Patent EP2234483.
HV304902 - JP 2009531018-A/469: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305400 - JP 2009531019-A/469: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV342469 - JP 2011510623-A/14: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HV492093 - WO 2011087154-A/266: Method For Screening Induced Pluripotent Stem Cells.
HV594121 - JP 2010538653-A/235: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595099 - JP 2010539959-A/480: Micromirs.
HV954105 - JP 2012518421-A/1017: METHODS OF DETECTING LUNG CANCER.
HW119609 - JP 2013046612-A/469: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW262297 - JP 2013516982-A/266: Method For Screening Induced Pluripotent Stem Cells.
HW589938 - JP 2013121348-A/469: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW818148 - JP 2015500013-A/75: Expression of miRNAs in placental tissue.
HZ043381 - JP 2015510401-A/471: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074188 - JP 2013535982-A/279: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082007 - JP 2015514392-A/471: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ083182 - JP 2015513906-A/539: Stem Cell Microparticles.
HZ157656 - JP 2015130862-A/480: Micromirs.
HZ186508 - JP 2015146814-A/257: Oligonucleotides for modulating target RNA activity.
HZ413742 - JP 2014060993-A/469: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ436963 - JP 2015529450-A/539: Stem Cell Microparticles.
HZ480048 - JP 2015535430-A/554: TERMINALLY MODIFIED RNA.
HZ501953 - JP 2016025853-A/469: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ789979 - JP 2016504050-A/1724: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401245 - Sequence 492 from Patent WO2011080318.
JA402223 - Sequence 492 from Patent WO2011080315.
JA403230 - Sequence 492 from Patent WO2011080316.
JA405861 - Sequence 492 from Patent EP2336353.
JA426857 - Sequence 190 from Patent WO2011072177.
JA429387 - Sequence 492 from Patent WO2011095623.
JA526319 - Sequence 469 from Patent EP2369011.
JA526826 - Sequence 469 from Patent EP2369012.
JA527333 - Sequence 469 from Patent EP2369013.
JA536262 - Sequence 469 from Patent EP2371971.
JA715235 - Sequence 1017 from Patent EP2401406.
JA788267 - Sequence 469 from Patent EP2479285.
JA788765 - Sequence 469 from Patent EP2479286.
JA791922 - Sequence 324 from Patent WO2012089772.
JA811099 - Sequence 469 from Patent EP2468890.
JA811597 - Sequence 469 from Patent EP2468891.
JA812095 - Sequence 469 from Patent EP2468893.
JA812593 - Sequence 469 from Patent EP2468894.
JA813091 - Sequence 469 from Patent EP2468895.
JA813589 - Sequence 469 from Patent EP2468896.
JA814087 - Sequence 469 from Patent EP2468897.
JA814585 - Sequence 469 from Patent EP2468898.
JA815083 - Sequence 469 from Patent EP2468899.
JA817326 - Sequence 469 from Patent EP2468892.
JA826138 - Sequence 469 from Patent EP2471956.
JA826636 - Sequence 469 from Patent EP2471958.
JB022425 - Sequence 267 from Patent WO2013026685.
JB024923 - Sequence 469 from Patent EP2505668.
JB025421 - Sequence 469 from Patent EP2505669.
JB079808 - Sequence 469 from Patent EP2487252.
JB080306 - Sequence 469 from Patent EP2487253.
JB080804 - Sequence 469 from Patent EP2487254.
JB081302 - Sequence 469 from Patent EP2487255.
JB081800 - Sequence 469 from Patent EP2487256.
JB082298 - Sequence 469 from Patent EP2487257.
JB082796 - Sequence 469 from Patent EP2487258.
JB083294 - Sequence 469 from Patent EP2487259.
JB083792 - Sequence 469 from Patent EP2487260.
JB084290 - Sequence 469 from Patent EP2487261.
JB084788 - Sequence 469 from Patent EP2487262.
JB085286 - Sequence 469 from Patent EP2487263.
JB087964 - Sequence 469 from Patent EP2502630.
JB148168 - Sequence 469 from Patent EP2484782.
JB148666 - Sequence 469 from Patent EP2484783.
JB153391 - Sequence 469 from Patent EP2514433.
JB153889 - Sequence 469 from Patent EP2514434.
JB620364 - Sequence 344 from Patent WO2013063544.
JB622478 - Sequence 469 from Patent EP2586454.
JB622976 - Sequence 469 from Patent EP2586455.
JB624415 - Sequence 235 from Patent EP2610342.
JB730453 - Sequence 75 from Patent WO2013079701.
JC002039 - Sequence 469 from Patent EP2591794.
JC017581 - Sequence 19 from Patent WO2013093870.
JC172167 - Sequence 539 from Patent WO2013150303.
JC208204 - Sequence 266 from Patent EP2524033.
JC334217 - Sequence 135 from Patent EP2487240.
JC512711 - Sequence 2964 from Patent WO2014113089.
JC572978 - Sequence 539 from Patent WO2014125276.
JC582666 - Sequence 539 from Patent WO2014125277.
JE954362 - Sequence 539 from Patent WO2015052526.
JE956115 - Sequence 539 from Patent WO2015052527.
LF137867 - JP 2016507550-A/539: Method of Producing Microparticles.
LF160126 - JP 2016513950-A/192: Oligomers with improved off-target profile.
LF162832 - JP 2016513095-A/539: Stem Cell Microparticles and miRNA.
LF401875 - JP 2015502976-A/19: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LF632744 - WO 2016117582-A/173: miRNA biomarkers for mental disorders.
LF953584 - JP 2016534103-A/539: Stem Cell Microparticles and miRNA.
LG005929 - KR 1020150004822-A/539: STEM CELL MICROPARTICLES.
LG053625 - KR 1020150059168-A/539: STEM CELL MICROPARTICLES.
LG240864 - KR 1020160035087-A/539: STEM CELL MICROPARTICLES AND MIRNA.
LP727104 - Sequence 798 from Patent EP2883966.
LP819374 - Sequence 798 from Patent EP3296406.
LP834191 - Sequence 75 from Patent EP3190186.
LP939316 - Sequence 798 from Patent EP3184651.
LQ070299 - Sequence 623 from Patent EP2964234.
LV470949 - JP 2016534036-A/539: Stem Cell Microparticles and miRNA.
LY405164 - KR 1020160117535-A/469: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ231632 - JP 2017186339-A/19: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LZ233865 - JP 2017184756-A/257: Oligonucleotides for modulating target RNA activity.
MA260403 - JP 2017505623-A/469: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS811000 - Sequence 4 from Patent EP3143123.
MS833530 - Sequence 235 from Patent EP3112464.
MS834346 - Sequence 492 from Patent EP3112479.
MS901794 - Sequence 267 from Patent EP3156505.
DM175418 - A nucleics Acid regulating cell growth.
DM208661 - Efficient Method for Nuclear Reprogramming.
FU261311 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763813 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525925 - Nucleic acid controling mast cell degranulation.
FW393704 - Efficient Method for Nuclear Reprogramming.
HV304712 - JP 2009531018-A/279: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305210 - JP 2009531019-A/279: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119419 - JP 2013046612-A/279: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589748 - JP 2013121348-A/279: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW818143 - JP 2015500013-A/70: Expression of miRNAs in placental tissue.
HZ408370 - JP 2015528002-A/967: CHIRAL CONTROL.
HZ413552 - JP 2014060993-A/279: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501763 - JP 2016025853-A/279: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526129 - Sequence 279 from Patent EP2369011.
JA526636 - Sequence 279 from Patent EP2369012.
JA527143 - Sequence 279 from Patent EP2369013.
JA536072 - Sequence 279 from Patent EP2371971.
JA788077 - Sequence 279 from Patent EP2479285.
JA788575 - Sequence 279 from Patent EP2479286.
JA810909 - Sequence 279 from Patent EP2468890.
JA811407 - Sequence 279 from Patent EP2468891.
JA811905 - Sequence 279 from Patent EP2468893.
JA812403 - Sequence 279 from Patent EP2468894.
JA812901 - Sequence 279 from Patent EP2468895.
JA813399 - Sequence 279 from Patent EP2468896.
JA813897 - Sequence 279 from Patent EP2468897.
JA814395 - Sequence 279 from Patent EP2468898.
JA814893 - Sequence 279 from Patent EP2468899.
JA817136 - Sequence 279 from Patent EP2468892.
JA818633 - Sequence 5 from Patent EP2474617.
JA825948 - Sequence 279 from Patent EP2471956.
JA826446 - Sequence 279 from Patent EP2471958.
JB024733 - Sequence 279 from Patent EP2505668.
JB025231 - Sequence 279 from Patent EP2505669.
JB079618 - Sequence 279 from Patent EP2487252.
JB080116 - Sequence 279 from Patent EP2487253.
JB080614 - Sequence 279 from Patent EP2487254.
JB081112 - Sequence 279 from Patent EP2487255.
JB081610 - Sequence 279 from Patent EP2487256.
JB082108 - Sequence 279 from Patent EP2487257.
JB082606 - Sequence 279 from Patent EP2487258.
JB083104 - Sequence 279 from Patent EP2487259.
JB083602 - Sequence 279 from Patent EP2487260.
JB084100 - Sequence 279 from Patent EP2487261.
JB084598 - Sequence 279 from Patent EP2487262.
JB085096 - Sequence 279 from Patent EP2487263.
JB087774 - Sequence 279 from Patent EP2502630.
JB147978 - Sequence 279 from Patent EP2484782.
JB148476 - Sequence 279 from Patent EP2484783.
JB153201 - Sequence 279 from Patent EP2514433.
JB153699 - Sequence 279 from Patent EP2514434.
JB622288 - Sequence 279 from Patent EP2586454.
JB622786 - Sequence 279 from Patent EP2586455.
JB730448 - Sequence 70 from Patent WO2013079701.
JC001849 - Sequence 279 from Patent EP2591794.
LG051704 - KR 1020150036642-A/970: CHIRAL CONTROL.
LP834186 - Sequence 70 from Patent EP3190186.
CS548386 - Sequence 1416 from Patent EP1777301.
DJ087796 - Novel miRNA molecules isolated from human embryonic stem cell.
DM175270 - A nucleics Acid regulating cell growth.
FU261500 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU764002 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525663 - Nucleic acid controling mast cell degranulation.
FW312125 - DETECTING NUCLEIC ACIDS.
FW364192 - Oligonucleotides for modulating target RNA activity.
HI561017 - Sequence 232 from Patent EP2190992.
HI965210 - Sequence 495 from Patent WO2010139812.
HI965728 - Sequence 48 from Patent WO2010139811.
HI966594 - Sequence 48 from Patent WO2010139810.
HV304901 - JP 2009531018-A/468: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305399 - JP 2009531019-A/468: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV492096 - WO 2011087154-A/269: Method For Screening Induced Pluripotent Stem Cells.
HV514192 - WO 2011102444-A/16: METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS.
HV593825 - JP 2010538610-A/38: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV594118 - JP 2010538653-A/232: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595096 - JP 2010539959-A/477: Micromirs.
HV954104 - JP 2012518421-A/1016: METHODS OF DETECTING LUNG CANCER.
HW119608 - JP 2013046612-A/468: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW262300 - JP 2013516982-A/269: Method For Screening Induced Pluripotent Stem Cells.
HW589937 - JP 2013121348-A/468: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW608543 - JP 2014515024-A/32: Micro-RNA Inhibitors and Their Uses in Disease.
HW669802 - JP 2013537538-A/533: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW818144 - JP 2015500013-A/71: Expression of miRNAs in placental tissue.
HZ074187 - JP 2013535982-A/278: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083101 - JP 2015513906-A/458: Stem Cell Microparticles.
HZ157653 - JP 2015130862-A/477: Micromirs.
HZ186505 - JP 2015146814-A/254: Oligonucleotides for modulating target RNA activity.
HZ413741 - JP 2014060993-A/468: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ436882 - JP 2015529450-A/458: Stem Cell Microparticles.
HZ480045 - JP 2015535430-A/551: TERMINALLY MODIFIED RNA.
HZ501952 - JP 2016025853-A/468: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ789976 - JP 2016504050-A/1721: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401248 - Sequence 495 from Patent WO2011080318.
JA402226 - Sequence 495 from Patent WO2011080315.
JA403233 - Sequence 495 from Patent WO2011080316.
JA405864 - Sequence 495 from Patent EP2336353.
JA426886 - Sequence 219 from Patent WO2011072177.
JA429390 - Sequence 495 from Patent WO2011095623.
JA526318 - Sequence 468 from Patent EP2369011.
JA526825 - Sequence 468 from Patent EP2369012.
JA527332 - Sequence 468 from Patent EP2369013.
JA536261 - Sequence 468 from Patent EP2371971.
JA660734 - Sequence 188 from Patent WO2011131354.
JA715234 - Sequence 1016 from Patent EP2401406.
JA788266 - Sequence 468 from Patent EP2479285.
JA788764 - Sequence 468 from Patent EP2479286.
JA792210 - Sequence 259 from Patent WO2012089753.
JA811098 - Sequence 468 from Patent EP2468890.
JA811596 - Sequence 468 from Patent EP2468891.
JA812094 - Sequence 468 from Patent EP2468893.
JA812592 - Sequence 468 from Patent EP2468894.
JA813090 - Sequence 468 from Patent EP2468895.
JA813588 - Sequence 468 from Patent EP2468896.
JA814086 - Sequence 468 from Patent EP2468897.
JA814584 - Sequence 468 from Patent EP2468898.
JA815082 - Sequence 468 from Patent EP2468899.
JA817325 - Sequence 468 from Patent EP2468892.
JA818651 - Sequence 23 from Patent EP2474617.
JA818714 - Sequence 86 from Patent EP2474617.
JA826137 - Sequence 468 from Patent EP2471956.
JA826635 - Sequence 468 from Patent EP2471958.
JB022452 - Sequence 294 from Patent WO2013026685.
JB022933 - Sequence 187 from Patent WO2013026684.
JB024922 - Sequence 468 from Patent EP2505668.
JB025420 - Sequence 468 from Patent EP2505669.
JB079807 - Sequence 468 from Patent EP2487252.
JB080305 - Sequence 468 from Patent EP2487253.
JB080803 - Sequence 468 from Patent EP2487254.
JB081301 - Sequence 468 from Patent EP2487255.
JB081799 - Sequence 468 from Patent EP2487256.
JB082297 - Sequence 468 from Patent EP2487257.
JB082795 - Sequence 468 from Patent EP2487258.
JB083293 - Sequence 468 from Patent EP2487259.
JB083791 - Sequence 468 from Patent EP2487260.
JB084289 - Sequence 468 from Patent EP2487261.
JB084787 - Sequence 468 from Patent EP2487262.
JB085285 - Sequence 468 from Patent EP2487263.
JB087963 - Sequence 468 from Patent EP2502630.
JB148167 - Sequence 468 from Patent EP2484782.
JB148665 - Sequence 468 from Patent EP2484783.
JB153390 - Sequence 468 from Patent EP2514433.
JB153888 - Sequence 468 from Patent EP2514434.
JB158044 - Sequence 32 from Patent WO2012142313.
JB175140 - Sequence 172 from Patent WO2012101219.
JB620363 - Sequence 343 from Patent WO2013063544.
JB622477 - Sequence 468 from Patent EP2586454.
JB622975 - Sequence 468 from Patent EP2586455.
JB624412 - Sequence 232 from Patent EP2610342.
JB730449 - Sequence 71 from Patent WO2013079701.
JC002038 - Sequence 468 from Patent EP2591794.
JC017579 - Sequence 17 from Patent WO2013093870.
JC172086 - Sequence 458 from Patent WO2013150303.
JC208207 - Sequence 269 from Patent EP2524033.
JC270142 - Sequence 533 from Patent WO2012020307.
JC334214 - Sequence 132 from Patent EP2487240.
JC504795 - Sequence 22 from Patent WO2014037574.
JC512708 - Sequence 2961 from Patent WO2014113089.
JC572897 - Sequence 458 from Patent WO2014125276.
JC582585 - Sequence 458 from Patent WO2014125277.
JE954281 - Sequence 458 from Patent WO2015052526.
JE956034 - Sequence 458 from Patent WO2015052527.
JE978743 - Sequence 188 from Patent EP2865765.
LF137786 - JP 2016507550-A/458: Method of Producing Microparticles.
LF159971 - JP 2016513950-A/37: Oligomers with improved off-target profile.
LF162751 - JP 2016513095-A/458: Stem Cell Microparticles and miRNA.
LF401873 - JP 2015502976-A/17: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LF857589 - JP 2015130879-A/38: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LF953503 - JP 2016534103-A/458: Stem Cell Microparticles and miRNA.
LG005848 - KR 1020150004822-A/458: STEM CELL MICROPARTICLES.
LG053544 - KR 1020150059168-A/458: STEM CELL MICROPARTICLES.
LG240783 - KR 1020160035087-A/458: STEM CELL MICROPARTICLES AND MIRNA.
LP726354 - Sequence 48 from Patent EP2883966.
LP818624 - Sequence 48 from Patent EP3296406.
LP834187 - Sequence 71 from Patent EP3190186.
LP938566 - Sequence 48 from Patent EP3184651.
LQ070296 - Sequence 620 from Patent EP2964234.
LQ278485 - Sequence 24 from Patent WO2016066288.
LQ500624 - Sequence 38 from Patent EP3048177.
LV470868 - JP 2016534036-A/458: Stem Cell Microparticles and miRNA.
LX270599 - JP 2016056210-A/533: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY405161 - KR 1020160117535-A/466: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ231630 - JP 2017186339-A/17: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LZ233862 - JP 2017184756-A/254: Oligonucleotides for modulating target RNA activity.
MA260400 - JP 2017505623-A/466: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673384 - Sequence 187 from Patent EP3135774.
MS810997 - Sequence 1 from Patent EP3143123.
MS833527 - Sequence 232 from Patent EP3112464.
MS834349 - Sequence 495 from Patent EP3112479.
MS901821 - Sequence 294 from Patent EP3156505.
MS904122 - Sequence 38 from Patent EP3138926.
JA818715 - Sequence 87 from Patent EP2474617.
CS548383 - Sequence 1413 from Patent EP1777301.
DJ087795 - Novel miRNA molecules isolated from human embryonic stem cell.
DM174472 - A nucleics Acid regulating cell growth.
FU261499 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU764001 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV524369 - Nucleic acid controling mast cell degranulation.
FW312126 - DETECTING NUCLEIC ACIDS.
HV304900 - JP 2009531018-A/467: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305398 - JP 2009531019-A/467: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV954103 - JP 2012518421-A/1015: METHODS OF DETECTING LUNG CANCER.
HW119607 - JP 2013046612-A/467: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589936 - JP 2013121348-A/467: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413740 - JP 2014060993-A/467: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501951 - JP 2016025853-A/467: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526317 - Sequence 467 from Patent EP2369011.
JA526824 - Sequence 467 from Patent EP2369012.
JA527331 - Sequence 467 from Patent EP2369013.
JA536260 - Sequence 467 from Patent EP2371971.
JA715233 - Sequence 1015 from Patent EP2401406.
JA788265 - Sequence 467 from Patent EP2479285.
JA788763 - Sequence 467 from Patent EP2479286.
JA811097 - Sequence 467 from Patent EP2468890.
JA811595 - Sequence 467 from Patent EP2468891.
JA812093 - Sequence 467 from Patent EP2468893.
JA812591 - Sequence 467 from Patent EP2468894.
JA813089 - Sequence 467 from Patent EP2468895.
JA813587 - Sequence 467 from Patent EP2468896.
JA814085 - Sequence 467 from Patent EP2468897.
JA814583 - Sequence 467 from Patent EP2468898.
JA815081 - Sequence 467 from Patent EP2468899.
JA817324 - Sequence 467 from Patent EP2468892.
JA826136 - Sequence 467 from Patent EP2471956.
JA826634 - Sequence 467 from Patent EP2471958.
JB024921 - Sequence 467 from Patent EP2505668.
JB025419 - Sequence 467 from Patent EP2505669.
JB079806 - Sequence 467 from Patent EP2487252.
JB080304 - Sequence 467 from Patent EP2487253.
JB080802 - Sequence 467 from Patent EP2487254.
JB081300 - Sequence 467 from Patent EP2487255.
JB081798 - Sequence 467 from Patent EP2487256.
JB082296 - Sequence 467 from Patent EP2487257.
JB082794 - Sequence 467 from Patent EP2487258.
JB083292 - Sequence 467 from Patent EP2487259.
JB083790 - Sequence 467 from Patent EP2487260.
JB084288 - Sequence 467 from Patent EP2487261.
JB084786 - Sequence 467 from Patent EP2487262.
JB085284 - Sequence 467 from Patent EP2487263.
JB087962 - Sequence 467 from Patent EP2502630.
JB148166 - Sequence 467 from Patent EP2484782.
JB148664 - Sequence 467 from Patent EP2484783.
JB153389 - Sequence 467 from Patent EP2514433.
JB153887 - Sequence 467 from Patent EP2514434.
JB622476 - Sequence 467 from Patent EP2586454.
JB622974 - Sequence 467 from Patent EP2586455.
JC002037 - Sequence 467 from Patent EP2591794.
JC334215 - Sequence 133 from Patent EP2487240.
MS810998 - Sequence 2 from Patent EP3143123.
FW364193 - Oligonucleotides for modulating target RNA activity.
HI561018 - Sequence 233 from Patent EP2190992.
HI965209 - Sequence 494 from Patent WO2010139812.
HI965830 - Sequence 150 from Patent WO2010139811.
HI966696 - Sequence 150 from Patent WO2010139810.
HV492094 - WO 2011087154-A/267: Method For Screening Induced Pluripotent Stem Cells.
HV593792 - JP 2010538610-A/5: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV594119 - JP 2010538653-A/233: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595097 - JP 2010539959-A/478: Micromirs.
HW262298 - JP 2013516982-A/267: Method For Screening Induced Pluripotent Stem Cells.
HW818145 - JP 2015500013-A/72: Expression of miRNAs in placental tissue.
HZ043363 - JP 2015510401-A/453: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074186 - JP 2013535982-A/277: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081989 - JP 2015514392-A/453: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ157654 - JP 2015130862-A/478: Micromirs.
HZ186506 - JP 2015146814-A/255: Oligonucleotides for modulating target RNA activity.
HZ480046 - JP 2015535430-A/552: TERMINALLY MODIFIED RNA.
HZ789977 - JP 2016504050-A/1722: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401247 - Sequence 494 from Patent WO2011080318.
JA402225 - Sequence 494 from Patent WO2011080315.
JA403232 - Sequence 494 from Patent WO2011080316.
JA405863 - Sequence 494 from Patent EP2336353.
JA429389 - Sequence 494 from Patent WO2011095623.
JA660707 - Sequence 161 from Patent WO2011131354.
JA818652 - Sequence 24 from Patent EP2474617.
JB023196 - Sequence 450 from Patent WO2013026684.
JB175339 - Sequence 371 from Patent WO2012101219.
JB620362 - Sequence 342 from Patent WO2013063544.
JB624413 - Sequence 233 from Patent EP2610342.
JB730450 - Sequence 72 from Patent WO2013079701.
JC011143 - Sequence 8 from Patent EP2639314.
JC208205 - Sequence 267 from Patent EP2524033.
JC244646 - Sequence 266 from Patent WO2012020308.
JC512709 - Sequence 2962 from Patent WO2014113089.
JE978716 - Sequence 161 from Patent EP2865765.
LF160218 - JP 2016513950-A/284: Oligomers with improved off-target profile.
LF404456 - JP 2015509366-A/449: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF857556 - JP 2015130879-A/5: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LP726456 - Sequence 150 from Patent EP2883966.
LP818726 - Sequence 150 from Patent EP3296406.
LP834188 - Sequence 72 from Patent EP3190186.
LP938668 - Sequence 150 from Patent EP3184651.
LQ070297 - Sequence 621 from Patent EP2964234.
LQ500591 - Sequence 5 from Patent EP3048177.
LY405162 - KR 1020160117535-A/467: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233863 - JP 2017184756-A/255: Oligonucleotides for modulating target RNA activity.
MA260401 - JP 2017505623-A/467: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA353987 - JP 2018075017-A/449: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MS673647 - Sequence 450 from Patent EP3135774.
MS833528 - Sequence 233 from Patent EP3112464.
MS834348 - Sequence 494 from Patent EP3112479.
MS904089 - Sequence 5 from Patent EP3138926.
MA644065 - JP 2017113010-A/1989: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731949 - JP 2017140048-A/819: TERMINALLY MODIFIED RNA.
MA644069 - JP 2017113010-A/1993: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731953 - JP 2017140048-A/823: TERMINALLY MODIFIED RNA.
MA643801 - JP 2017113010-A/1725: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731685 - JP 2017140048-A/555: TERMINALLY MODIFIED RNA.
MA643802 - JP 2017113010-A/1726: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731686 - JP 2017140048-A/556: TERMINALLY MODIFIED RNA.
MA643795 - JP 2017113010-A/1719: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730745 - JP 2017125065-A/532: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731679 - JP 2017140048-A/549: TERMINALLY MODIFIED RNA.
MA643796 - JP 2017113010-A/1720: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731680 - JP 2017140048-A/550: TERMINALLY MODIFIED RNA.
MA643799 - JP 2017113010-A/1723: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731683 - JP 2017140048-A/553: TERMINALLY MODIFIED RNA.
MA643800 - JP 2017113010-A/1724: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731684 - JP 2017140048-A/554: TERMINALLY MODIFIED RNA.
MA643797 - JP 2017113010-A/1721: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730746 - JP 2017125065-A/533: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731681 - JP 2017140048-A/551: TERMINALLY MODIFIED RNA.
MA643798 - JP 2017113010-A/1722: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731682 - JP 2017140048-A/552: TERMINALLY MODIFIED RNA.
MA783995 - WO 2018193902-A/6: ANTI-VIRAL EFFECT AGAINST HEPATITIS B VIRUS BY MICRO RNA.
MA393004 - JP 2018113924-A/5: A method for evaluating differentiation status of cells.
MA396635 - WO 2018135288-A/5: A method for evaluating differentiation status of cells.
MA393003 - JP 2018113924-A/4: A method for evaluating differentiation status of cells.
MA396634 - WO 2018135288-A/4: A method for evaluating differentiation status of cells.
MA393000 - JP 2018113924-A/1: A method for evaluating differentiation status of cells.
MA396631 - WO 2018135288-A/1: A method for evaluating differentiation status of cells.
MA393002 - JP 2018113924-A/3: A method for evaluating differentiation status of cells.
MA396633 - WO 2018135288-A/3: A method for evaluating differentiation status of cells.
MA393001 - JP 2018113924-A/2: A method for evaluating differentiation status of cells.
MA396632 - WO 2018135288-A/2: A method for evaluating differentiation status of cells.
LQ955725 - Sequence 56 from Patent EP2775001.
LQ955713 - Sequence 44 from Patent EP2775001.
LQ955707 - Sequence 38 from Patent EP2775001.
LQ955674 - Sequence 5 from Patent EP2775001.
MA406152 - WO 2018155427-A/926: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MP045297 - Sequence 119 from Patent EP3401394.
MP083967 - Sequence 119 from Patent EP3401393.
MP045222 - Sequence 44 from Patent EP3401394.
MP083892 - Sequence 44 from Patent EP3401393.
MP084320 - Sequence 472 from Patent EP3401393.
MP084318 - Sequence 470 from Patent EP3401393.
MP084319 - Sequence 471 from Patent EP3401393.
MP015057 - Sequence 260 from Patent WO2019016252.
MP045627 - Sequence 449 from Patent EP3401394.
MP084301 - Sequence 453 from Patent EP3401393.
MA801118 - JP 2018183181-A/1989: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA801122 - JP 2018183181-A/1993: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800854 - JP 2018183181-A/1725: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800855 - JP 2018183181-A/1726: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800848 - JP 2018183181-A/1719: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800849 - JP 2018183181-A/1720: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800852 - JP 2018183181-A/1723: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800853 - JP 2018183181-A/1724: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800850 - JP 2018183181-A/1721: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800851 - JP 2018183181-A/1722: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129560 - Sequence 460 from Patent EP3470073.
MP162483 - Sequence 460 from Patent WO2019069093.
MP135399 - Sequence 4 from Patent EP3464591.
MP129603 - Sequence 503 from Patent EP3470073.
MP162526 - Sequence 503 from Patent WO2019069093.
MP129611 - Sequence 511 from Patent EP3470073.
MP162534 - Sequence 511 from Patent WO2019069093.
MP129639 - Sequence 539 from Patent EP3470073.
MP162562 - Sequence 539 from Patent WO2019069093.
MP129558 - Sequence 458 from Patent EP3470073.
MP162481 - Sequence 458 from Patent WO2019069093.
MP280642 - Sequence 62 from Patent WO2019111197.
MP280624 - Sequence 44 from Patent WO2019111197.
MP283555 - Sequence 62 from Patent WO2019111198.
MP293304 - Sequence 58 from Patent EP3508854.
MP280754 - Sequence 174 from Patent WO2019111197.
MP283667 - Sequence 174 from Patent WO2019111198.
MP293305 - Sequence 59 from Patent EP3508854.
MP280753 - Sequence 173 from Patent WO2019111197.
MP283666 - Sequence 173 from Patent WO2019111198.
MP280749 - Sequence 169 from Patent WO2019111197.
MP283662 - Sequence 169 from Patent WO2019111198.
MP280748 - Sequence 168 from Patent WO2019111197.
MP283661 - Sequence 168 from Patent WO2019111198.
MP280752 - Sequence 172 from Patent WO2019111197.
MP283665 - Sequence 172 from Patent WO2019111198.
MP288029 - Sequence 4 from Patent EP3489352.
MP280751 - Sequence 171 from Patent WO2019111197.
MP283664 - Sequence 171 from Patent WO2019111198.
MP283537 - Sequence 44 from Patent WO2019111198.
MP280750 - Sequence 170 from Patent WO2019111197.
MP283663 - Sequence 170 from Patent WO2019111198.
LY615938 - KR 1020180107320-A/4: TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_029857
UCSC ID: uc011cfz.2
RefSeq Accession: NR_029857

-  Gene Model Information
 
category: noncoding nonsense-mediated-decay: no RNA accession: NR_029857.1
exon count: 1CDS single in 3' UTR: no RNA size: 73
ORF size: 0CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 276.00frame shift in genome: no % Coverage: 100.00
has start codon: no stop codon in genome: no # of Alignments: 1
has end codon: no retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.